-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Hematology Inclusion Pathway (HIP) Oral Presentations - Malignant Hematology

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Saturday, December 7, 2024: 6:00 PM-9:00 PM
Marina Ballroom D (Marriott Marquis San Diego Marina)
Moderators:
Anita D'Souza, MD, Medical College of Wisconsin and Jorge Monge, MD, University of Colorado Anschutz Medical Campus and Mazie Tsang, MD, Mayo Clinic
Disclosures:
Monge: Janssen: Consultancy; Johnson & Johnson: Consultancy; Pfizer: Consultancy. Tsang: AstraZeneca: Other: Advisory Board; Poseida Therapeutics: Current holder of stock options in a privately-held company; AVEO: Other: Prior holder of stock options in a privately-held company; Novartis: Other: Advisory Board; Genentech: Other: Advisory Board.
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.

John Roy R Lozada, MD

Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

Sofia E. Luna

Leland Stanford Stanford Junior University, Stanford, CA

Fathima Mohamed

Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN

Andres J Rubio, MS

Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine, El Paso, TX

Joane Titus, MD, MS

HCA Florida Healthcare GME Consortium, University of Central Florida, Orlando, FL

Kalay Bertulfo, MS, MA, MPhil

Institute for Cancer Genetics, Columbia University Irving Medical Center, New York, NY

Quenton Bubb, MPhil

Leland Stanford Junior University, Stanford, CA

Kristopher Adrian Knight

Molecular and Systems Pharmacology, Emory University, Atlanta, GA